Cagrilintide (Lyophilized Form)
CAS Number: 2134203-57-0
Molecular Formula: C₁₈₄H₂₉₆N₅₂O₅₇
Cagrilintide is a lyophilized synthetic peptide analog developed for scientific and laboratory research applications. It functions as a long-acting amylin receptor agonist, structurally modified to enhance stability and extend its biological activity profile in vivo.
Cagrilintide has been studied for its synergistic effects when combined with GLP-1 receptor agonists, particularly in the context of appetite regulation, body weight management, and metabolic signaling. Its mechanism involves modulation of satiety-related pathways and delayed gastric emptying, making it a compound of interest in obesity and metabolic research.
Investigations into metabolic regulation and energy homeostasis
Research on amylin and GLP-1 receptor interactions
Preclinical studies in obesity and appetite signaling models
Form: Lyophilized powder
Purity: ≥ 98% (HPLC)
Storage Conditions: Store at –20 °C, protected from light and moisture
Reconstitution: Recommended with sterile water or buffer prior to use
Intended Use: For research use only. Not for human or veterinary application
This material is intended solely for laboratory research. Handle in accordance with good laboratory practices and institutional safety standards.
All products sold by NextGen are intended strictly for laboratory research and development purposes, including in vitro and approved in vivo studies in animals, by qualified professionals only. These products are not medicines, supplements, or therapeutic substances, have not been evaluated or approved by the FDA, and are not intended for human use, consumption, diagnosis, or treatment.